Negative Pressure Wound Therapy Market - Global Forecast To 2030
商品番号 : SMB-79110
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年5月 |
| ページ数 | 249 |
| 図表数 | 279 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、製品タイプ、創傷タイプ、エンドユーザー、および国別に、陰圧創傷治療市場を分析しています。また、市場成長に影響を与える要因（促進要因、抑制要因、機会、課題など）を分析するとともに、市場リーダー企業の競争環境の詳細も提供しています。さらに、ミクロ市場を個々の成長傾向の観点から分析しています。さらに、5つの主要地域（および各地域に属する国）における市場セグメントの収益予測も提供しています。
The global negative pressure wound therapy market is projected to reach USD 3.84 billion by 2030 from USD 2.76 billion in 2025, at a CAGR of 6.9% during the forecast period.
世界の陰圧創傷治療市場は、予測期間中に6.9%のCAGRで成長し、2025年の27億6,000万米ドルから2030年には38億4,000万米ドルに達すると予測されています。
This is due to the increasing rise of diabetic patients, rising cases of traumatic injuries and burn injuries, and the growing geriatric population, which drives market growth. Additionally, rising usage of simplified single-use devices is expected to impact market growth.
これは、糖尿病患者の増加、外傷や火傷の増加、そして高齢者人口の増加によるもので、これらが市場の成長を牽引しています。さらに、簡素化された使い捨てデバイスの利用増加も市場の成長に影響を与えると予想されます。
“The hospitals segment of the negative pressure wound therapy market, by end user, is expected to hold the largest position during the forecast period.”
Based on the end user, the negative pressure wound therapy market is divided into home care settings, hospitals, and other end users. Among these, hospitals hold the largest market share in 2024. The need for advanced wound care products in hospitals has been further stimulated by the rising incidence of diabetic foot ulcers and post-operative wounds. Hospital visits for wound care have also increased as a result of the growing geriatric population with chronic illnesses, including diabetes and vascular diseases. Hospitals can treat wounds quickly and effectively due to established protocols, knowledgeable medical staff, and a wide range of traditional wound care materials. As a result of the increased focus on improving wound care practices and patient recovery rates, this market segment continues to hold its dominant position.
“The burns and surgical & open wounds accounted for the largest market share in the negative pressure wound therapy market.”
The negative pressure wound therapy market is segmented into burns and surgical & open wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers, and traumatic wounds. The burns and surgical & open wounds segment accounted for the largest share in the negative pressure wound therapy market in 2024. Burns and surgical & open wounds are leading segments in the negative pressure wound therapy market due to their rising occurrence and complexity, which require advanced wound management solutions. NPWT devices are particularly effective in managing these types of wounds, as they promote quicker healing, reduce infection risk, and improve tissue regeneration. Surgical wounds involving large incisions or at risk of dehiscence benefit significantly from maintaining a clean, moist wound environment and reducing edema.
“Asia Pacific is the fastest-growing region of the negative pressure wound therapy market by region.”
The global negative pressure wound therapy market is segmented into five segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific negative pressure wound therapy market is growing due to the geriatric population, rising healthcare costs, and a growing incidence of chronic wounds. Asia Pacific offers high growth opportunities for players in the market. This segment is slated to register the highest CAGR during the forecast period.
As the number of surgeries, road accidents, and burn cases increases, there is an increasing need for effective wound care therapies. The growing incidence of diabetes has led to a rise in diabetic foot ulcers, highlighting the significance of proper wound care. The expansion of the healthcare system, e-commerce, and pharmacies has made the negative pressure wound therapy product accessible than ever. As awareness of wound care improves and healthcare services advance, the demand for negative pressure wound therapy solutions in the Mexico region is expected to see continued growth.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1: 38%, Tier 2: 29%, and Tier 3: 33%
- By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
- By Region: North America: 50%, Europe: 20%, Asia Pacific: 20%, Latin America: 7%, and Middle East & Africa: 3%
Note 1: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the negative pressure wound therapy market are Solventum (US), Smith+Nephew (UK), Cardinal Health (US), Mölnlycke AB (Sweden), Convatec Group PLC (UK), PAUL HARTMANN AG (Germany), Avery Dennison Corporation (US), BenQ Materials Corporation (Taiwan), Double Medical Technology Inc. (China), Advanced Oxygen Therapy Inc. (US), and Carilex Medical (Taiwan).
Research Coverage
This report studies the negative pressure wound therapy market based on product type, wound type, end user, and country. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.
This report provides insights on the following pointers:
- Analysis of key drivers (booming geriatric population, increasing cases of traumatic injuries, growing prevalence of chronic diseases rising incidence of burn injuriesand favorable government and industry initiatives and reimbursements), restraints (high cost of negative pressure wound devices,and risks associated with use of negative pressure wound therapy products), opportunities (high growth opportunities in emerging economiesand growing usage of simplified single-use devices), challenges (availability of alternative therapies, and Limited awareness among healthcare providers)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the negative pressure wound therapy market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the negative pressure wound therapy market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the negative pressure wound therapy market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
Table of Contents
1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.3 STUDY SCOPE 27
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 27
1.3.2 INCLUSIONS AND EXCLUSIONS 28
1.3.3 YEARS CONSIDERED 28
1.4 CURRENCY CONSIDERED 29
1.5 STAKEHOLDERS 29
1.6 SUMMARY OF CHANGES 29
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
2.1.1 SECONDARY DATA 31
2.1.1.1 Key data from secondary sources 32
2.1.2 PRIMARY DATA 33
2.1.2.1 Primary sources 33
2.1.2.2 Key industry insights 34
2.1.2.3 Key data from primary sources 34
2.1.2.4 Breakdown of primary interviews 35
2.2 MARKET SIZE ESTIMATION 35
2.2.1 BOTTOM-UP APPROACH 36
2.2.1.1 Approach 1: Company revenue estimation approach 36
2.2.1.2 Approach 2: Presentations of companies and primary interviews 36
2.2.1.3 Approach 3: Primary interviews 36
2.2.1.4 Growth forecast 37
2.2.1.5 CAGR projections 37
2.2.2 TOP-DOWN APPROACH 38
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 39
2.4 RESEARCH ASSUMPTIONS 40
2.4.1 STUDY-RELATED ASSUMPTIONS 40
2.4.2 PARAMETRIC ASSUMPTIONS 40
2.4.3 GROWTH RATE ASSUMPTIONS 40
2.5 RESEARCH LIMITATIONS 41
2.6 RISK ASSESSMENT 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 46
4.1 NEGATIVE PRESSURE WOUND THERAPY MARKET OVERVIEW 46
4.2 ASIA PACIFIC NEGATIVE PRESSURE WOUND THERAPY MARKET,
BY END USER AND COUNTRY 47
4.3 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY KEY COUNTRY 48
4.4 NEGATIVE PRESSURE WOUND THERAPY MARKET, REGIONAL MIX, 2025 VS. 2030 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
5.2.1 DRIVERS 50
5.2.1.1 Booming geriatric population 50
5.2.1.2 Increasing cases of traumatic injuries 50
5.2.1.3 Growing prevalence of chronic diseases 51
5.2.1.4 Rising incidence of burn injuries 52
5.2.1.5 Favorable government and industry initiatives and reimbursement policies 53
5.2.2 RESTRAINTS 54
5.2.2.1 High cost of negative pressure wound therapy devices 54
5.2.2.2 Risks associated with use of negative pressure wound therapy products 54
5.2.3 OPPORTUNITIES 55
5.2.3.1 Growth opportunities in emerging economies 55
5.2.3.2 Increasing use of simplified single-use devices 56
5.2.4 CHALLENGES 56
5.2.4.1 Availability of alternative therapies 56
5.2.4.2 Limited awareness among healthcare providers 56
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 57
5.4 PRICING ANALYSIS 57
5.4.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 58
5.4.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 58
5.4.3 AVERAGE SELLING PRICE TREND, BY REGION 59
5.5 VALUE CHAIN ANALYSIS 59
5.6 SUPPLY CHAIN ANALYSIS 61
5.7 ECOSYSTEM ANALYSIS 62
5.8 INVESTMENT AND FUNDING SCENARIO 63
5.9 TECHNOLOGY ANALYSIS 64
5.9.1 KEY TECHNOLOGIES 64
5.9.1.1 Vacuum-assisted Closure (VAC) Therapy 64
5.9.2 COMPLEMENTARY TECHNOLOGIES 64
5.9.2.1 Topical Oxygen Therapy 64
5.9.3 ADJACENT TECHNOLOGIES 65
5.9.3.1 Hyperbaric Oxygen Therapy 65
5.10 PATENT ANALYSIS 65
5.11 TRADE ANALYSIS 67
5.11.1 IMPORT DATA (HS CODE 901890) 67
5.11.2 EXPORT DATA (HS CODE 901890) 67
5.12 KEY CONFERENCES AND EVENTS, 2025–2026 68
5.13 CASE STUDY ANALYSIS 69
5.13.1 CASE STUDY 1: COMPLEX WOUND HEALING WITH TOPICAL NEGATIVE PRESSURE WOUND THERAPY 69
5.13.2 CASE STUDY 2: NECROTIZING FASCIITIS MANAGED WITH NEGATIVE PRESSURE WOUND THERAPY FOR BETTER WOUND CLOSURE 70
5.13.3 CASE STUDY 3: TREATMENT OF HARD-TO-HEAL WOUNDS WITH PORTABLE NEGATIVE PRESSURE WOUND THERAPY 70
5.14 REGULATORY LANDSCAPE 71
5.14.1 REGULATORY ANALYSIS 71
5.14.1.1 North America 71
5.14.1.1.1 US 71
5.14.1.1.2 Canada 71
5.14.1.2 Europe 71
5.14.1.2.1 Germany 72
5.14.1.2.2 UK 72
5.14.1.2.3 France 72
5.14.1.3 Asia Pacific 72
5.14.1.3.1 China 72
5.14.1.3.2 Japan 73
5.14.1.3.3 India 73
5.14.1.4 Latin America 73
5.14.1.5 Middle East 74
5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
5.14.2.1 North America 74
5.14.2.2 Europe 75
5.14.2.3 Asia Pacific 75
5.14.2.4 Latin America 76
5.14.2.5 Rest of the World 76
5.15 PORTER’S FIVE FORCES ANALYSIS 77
5.15.1 BARGAINING POWER OF SUPPLIERS 78
5.15.2 BARGAINING POWER OF BUYERS 78
5.15.3 THREAT OF NEW ENTRANTS 78
5.15.4 THREAT OF SUBSTITUTES 78
5.15.5 INTENSITY OF COMPETITIVE RIVALRY 78
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 79
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 79
5.16.2 BUYING CRITERIA 80
5.17 IMPACT OF AI ON NEGATIVE PRESSURE WOUND THERAPY MARKET 80
5.17.1 INTRODUCTION 80
5.17.2 MARKET POTENTIAL OF AI IN NEGATIVE PRESSURE WOUND THERAPY MARKET 81
5.17.3 AI USE CASES 81
5.17.4 KEY COMPANIES IMPLEMENTING AI 82
5.17.5 FUTURE OF AI IN NEGATIVE PRESSURE WOUND THERAPY MARKET 82
5.18 IMPACT OF US TARIFF REGULATION ON NEGATIVE
PRESSURE WOUND THERAPY MARKET 82
5.18.1 INTRODUCTION 82
5.18.2 KEY TARIFF RATES 83
5.18.3 PRICE IMPACT ANALYSIS 83
5.18.4 KEY IMPACT ON COUNTRY/REGION 84
5.18.4.1 North America 84
5.18.4.2 Europe 84
5.18.4.3 Asia Pacific 84
5.18.5 IMPACT ON END-USE INDUSTRIES 84
5.18.5.1 Hospitals 85
6 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE 86
6.1 INTRODUCTION 87
6.2 CONVENTIONAL NPWT DEVICES 87
6.2.1 RISING FOCUS ON EFFECTIVE WOUND MANAGEMENT TO EXPEDITE GROWTH 87
6.3 SINGLE-USE NPWT DEVICES 90
6.3.1 INCREASING ADOPTION OF SINGLE-USE DEVICES IN HOME HEALTHCARE TO PROMOTE GROWTH 90
6.4 NPWT ACCESSORIES & CONSUMABLES 93
6.4.1 GROWING PREVALENCE OF CHRONIC WOUNDS TO DRIVE MARKET 93
7 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE 97
7.1 INTRODUCTION 98
7.2 BURNS AND SURGICAL & OPEN WOUNDS 98
7.2.1 HIGH INCIDENCE OF BURN INJURIES IN LOW AND MIDDLE-INCOME COUNTRIES TO AID GROWTH 98
7.3 PRESSURE ULCERS 101
7.3.1 INCREASING AGING POPULATION WORLDWIDE TO AUGMENT GROWTH 101
7.4 DIABETIC FOOT ULCERS 104
7.4.1 INCREASE PREVALENCE OF DIABETES TO STIMULATE GROWTH 104
7.5 VENOUS LEG ULCERS 107
7.5.1 RISING PREVALENCE OF OBESITY TO CONTRIBUTE TO GROWTH 107
7.6 TRAUMATIC WOUNDS 110
7.6.1 GROWING INCIDENCE OF TRAUMATIC INJURIES TO BOOST MARKET 110
8 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER 114
8.1 INTRODUCTION 115
8.2 HOSPITALS 115
8.2.1 RISING NUMBER OF SURGERIES TO ACCELERATE GROWTH 115
8.3 HOME CARE SETTINGS 118
8.3.1 INCREASING HEALTHCARE EXPENDITURE TO SPEED UP GROWTH 118
8.4 OTHER END USERS 121
9 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY REGION 124
9.1 INTRODUCTION 125
9.2 NORTH AMERICA 125
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 126
9.2.2 US 129
9.2.2.1 Rising regulatory approvals and favorable reimbursement policies to stimulate growth 129
9.2.3 CANADA 131
9.2.3.1 Increasing prevalence of diabetes to support growth 131
9.3 EUROPE 133
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 134
9.3.2 UK 136
9.3.2.1 Increase in research & development activities to aid growth 136
9.3.3 GERMANY 138
9.3.3.1 Growing prevalence of hospital-acquired infections to propel market 138
9.3.4 FRANCE 140
9.3.4.1 Rise in healthcare budget to spur growth 140
9.3.5 ITALY 141
9.3.5.1 Increasing national healthcare funding to favor growth 141
9.3.6 SPAIN 143
9.3.6.1 Increasing number of surgical procedures to promote growth 143
9.3.7 RUSSIA 145
9.3.7.1 Escalating diabetes issue to drive market 145
9.3.8 REST OF EUROPE 146
9.4 ASIA PACIFIC 148
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 149
9.4.2 CHINA 152
9.4.2.1 Increasing incidence of diabetic foot ulcers to encourage growth 152
9.4.3 JAPAN 154
9.4.3.1 Evolving healthcare delivery and infrastructure landscape to fuel market 154
9.4.4 INDIA 156
9.4.4.1 Booming medical tourism to speed up growth 156
9.4.5 AUSTRALIA 158
9.4.5.1 Growing focus on diabetes management to drive market 158
9.4.6 SOUTH KOREA 159
9.4.6.1 Increasing awareness and focus on advanced wound care therapies to facilitate growth 159
9.4.7 SINGAPORE 161
9.4.7.1 Increasing healthcare spending to sustain growth 161
9.4.8 REST OF ASIA PACIFIC 162
9.5 LATIN AMERICA 164
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 164
9.5.2 BRAZIL 166
9.5.2.1 Free healthcare services to bolster growth 166
9.5.3 MEXICO 168
9.5.3.1 Expanding hospital infrastructure to aid growth 168
9.5.4 REST OF LATIN AMERICA 169
9.6 MIDDLE EAST & AFRICA 171
9.6.1 GROWING DEMAND FOR HEALTHCARE FACILITIES TO DRIVE MARKET 171
9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 171
10 COMPETITIVE LANDSCAPE 173
10.1 OVERVIEW 173
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024 173
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN NEGATIVE PRESSURE WOUND THERAPY MARKET 174
10.3 REVENUE ANALYSIS, 2022–2024 175
10.4 MARKET SHARE ANALYSIS, 2024 176
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 178
10.5.1 STARS 178
10.5.2 EMERGING LEADERS 178
10.5.3 PERVASIVE PLAYERS 179
10.5.4 PARTICIPANTS 179
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 180
10.5.5.1 Company footprint 180
10.5.5.2 Region footprint 181
10.5.5.3 Product type footprint 182
10.5.5.4 Wound type footprint 183
10.5.5.5 End-user footprint 184
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 184
10.6.1 PROGRESSIVE COMPANIES 184
10.6.2 RESPONSIVE COMPANIES 184
10.6.3 DYNAMIC COMPANIES 185
10.6.4 STARTING BLOCKS 185
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 186
10.6.5.1 Detailed list of key startups/SMEs 186
10.6.5.2 Competitive benchmarking of key startups/SMEs 187
10.7 COMPANY VALUATION AND FINANCIAL METRICS 188
10.7.1 COMPANY VALUATION 188
10.7.2 FINANCIAL METRICS 188
10.8 BRAND/PRODUCT COMPARISON 189
10.9 COMPETITIVE SCENARIO 190
10.9.1 PRODUCT LAUNCHES AND APPROVALS 190
10.9.2 DEALS 190
10.9.3 EXPANSIONS 192
10.9.4 OTHER DEVELOPMENTS 193
11 COMPANY PROFILES 194
11.1 KEY PLAYERS 194
11.1.1 SOLVENTUM 194
11.1.1.1 Business overview 194
11.1.1.2 Products offered 195
11.1.1.3 Recent developments 196
11.1.1.3.1 Product launches and approvals 196
11.1.1.3.2 Other developments 196
11.1.1.4 MnM view 197
11.1.1.4.1 Key strengths 197
11.1.1.4.2 Strategic choices 197
11.1.1.4.3 Weaknesses and competitive threats 197
11.1.2 SMITH+NEPHEW 198
11.1.2.1 Business overview 198
11.1.2.2 Products offered 199
11.1.2.3 Recent developments 200
11.1.2.3.1 Product launches and approvals 200
11.1.2.3.2 Deals 200
11.1.2.3.3 Expansions 201
11.1.2.4 MnM view 201
11.1.2.4.1 Key strengths 201
11.1.2.4.2 Strategic choices 201
11.1.2.4.3 Weaknesses and competitive threats 202
11.1.3 CARDINAL HEALTH 203
11.1.3.1 Business overview 203
11.1.3.2 Products offered 204
11.1.3.3 Recent developments 205
11.1.3.3.1 Deals 205
11.1.3.3.2 Expansions 206
11.1.3.4 MnM view 207
11.1.3.4.1 Key strengths 207
11.1.3.4.2 Strategic choices 207
11.1.3.4.3 Weaknesses and competitive threats 207
11.1.4 MÖLNLYCKE AB 208
11.1.4.1 Business overview 208
11.1.4.2 Products offered 209
11.1.4.3 Recent developments 210
11.1.4.3.1 Deals 210
11.1.4.4 MnM view 211
11.1.4.4.1 Key strengths 211
11.1.4.4.2 Strategic choices 211
11.1.4.4.3 Weaknesses and competitive threats 211
11.1.5 CONVATEC GROUP PLC 212
11.1.5.1 Business overview 212
11.1.5.2 Products offered 213
11.1.5.3 Recent developments 214
11.1.5.3.1 Deals 214
11.1.5.4 MnM view 214
11.1.5.4.1 Key strengths 214
11.1.5.4.2 Strategic choices 214
11.1.5.4.3 Weaknesses and competitive threats 214
11.1.6 PAUL HARTMANN AG 215
11.1.6.1 Business overview 215
11.1.6.2 Products offered 216
11.1.6.3 Recent developments 217
11.1.6.3.1 Deals 217
11.1.7 AVERY DENNISON CORPORATION 218
11.1.7.1 Business overview 218
11.1.7.2 Products offered 219
11.1.7.3 Recent developments 220
11.1.7.3.1 Deals 220
11.1.7.3.2 Expansions 220
11.1.8 BENQ MATERIALS CORPORATION 221
11.1.8.1 Business overview 221
11.1.8.2 Products offered 222
11.1.8.3 Recent developments 223
11.1.8.3.1 Deals 223
11.1.8.3.2 Other developments 223
11.1.9 ADVANCED OXYGEN THERAPY INC. 224
11.1.9.1 Business overview 224
11.1.9.2 Products offered 225
11.1.9.3 Recent developments 225
11.1.9.3.1 Product launches and approvals 225
11.2 OTHER PLAYERS 226
11.2.1 DOUBLE MEDICAL TECHNOLOGY INC. 226
11.2.2 CARILEX MEDICAL 227
11.2.3 DEROYAL INDUSTRIES, INC. 228
11.2.4 LOHMANN & RAUSCHER GMBH & CO. KG 229
11.2.5 MEDAXIS LLC 230
11.2.6 GENADYNE BIOTECHNOLOGIES, INC. 231
11.2.7 DIRECT HEALTHCARE GROUP 232
11.2.8 ALLEVA MEDICAL 233
11.2.9 CORK MEDICAL, LLC 234
11.2.10 PENSAR MEDICAL 235
11.2.11 HAROMED 236
11.2.12 GUANGZHOU RAINHOME PHARM & TECH CO., LTD. 237
11.2.13 GUARD MEDICAL 238
11.2.14 DATT MEDIPRODUCTS PRIVATE LIMITED 239
11.2.15 KORAZON MEDICAL DEVICES PRIVATE LIMITED 240
11.2.16 TRIAGE MEDITECH PVT. LTD. 241
12 APPENDIX 242
12.1 DISCUSSION GUIDE 242
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 245
12.3 CUSTOMIZATION OPTIONS 247
12.4 RELATED REPORTS 247
12.5 AUTHOR DETAILS 248
LIST OF TABLES
TABLE 1 NEGATIVE PRESSURE WOUND THERAPY MARKET: INCLUSIONS AND EXCLUSIONS 28
TABLE 2 NEGATIVE PRESSURE WOUND THERAPY MARKET: RISK ASSESSMENT 41
TABLE 3 POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION), 2023 50
TABLE 4 ROAD ACCIDENT DEMOGRAPHIC, 2022 51
TABLE 5 CHINA: STATES ON DISCHARGE OF PATIENTS WITH TYPE 2 DFU IN DIFFERENT AGE GROUPS, JANUARY 2017–DECEMBER 2023 52
TABLE 6 RISKS ASSOCIATED WITH NEGATIVE PRESSURE WOUND THERAPY DEVICES 55
TABLE 7 STRATEGIC DEVELOPMENTS IN ASIA PACIFIC, 2023–2024 55
TABLE 8 AVERAGE SELLING PRICING TREND OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS, 2023–2025 58
TABLE 9 AVERAGE SELLING PRICE TREND OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS, BY KEY PLAYER, 2023–2025 58
TABLE 10 AVERAGE SELLING PRICE TREND OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS, BY REGION, 2023–2025 59
TABLE 11 NEGATIVE PRESSURE WOUND THERAPY MARKET: ROLE OF COMPANIES IN ECOSYSTEM 63
TABLE 12 NEGATIVE PRESSURE WOUND THERAPY MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024 66
TABLE 13 IMPORT DATA (HS CODE 901890), BY COUNTRY, 2020–2024 (USD MILLION) 67
TABLE 14 EXPORT DATA (HS CODE 901890), BY COUNTRY, 2020–2024 (USD MILLION) 67
TABLE 15 NEGATIVE PRESSURE WOUND THERAPY MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 68
TABLE 16 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN 73
TABLE 17 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 18 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 19 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 20 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 21 REST OF THE WORLD: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 22 NEGATIVE PRESSURE WOUND THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS 77
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS (%) 79
TABLE 24 KEY BUYING CRITERIA FOR NEGATIVE PRESSURE WOUND THERAPY PRODUCTS 80
TABLE 25 US ADJUSTED RECIPROCAL TARIFF RATES 83
TABLE 26 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 87
TABLE 27 KEY COMPANIES OFFERING CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES 88
TABLE 28 CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET,
BY REGION, 2023–2030 (USD MILLION) 88
TABLE 29 NORTH AMERICA: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 88
TABLE 30 EUROPE: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 89
TABLE 31 ASIA PACIFIC: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 89
TABLE 32 LATIN AMERICA: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 90
TABLE 33 KEY COMPANIES OFFERING SINGLE-USE NEGATIVE PRESSURE WOUND
THERAPY DEVICES 91
TABLE 34 SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET,
BY REGION, 2023–2030 (USD MILLION) 91
TABLE 35 NORTH AMERICA: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 91
TABLE 36 EUROPE: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 92
TABLE 37 ASIA PACIFIC: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 92
TABLE 38 LATIN AMERICA: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 93
TABLE 39 KEY COMPANIES OFFERING NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES 94
TABLE 40 NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 94
TABLE 41 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 94
TABLE 42 EUROPE: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 95
TABLE 43 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 95
TABLE 44 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 96
TABLE 45 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 98
TABLE 46 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY REGION, 2023–2030 (USD MILLION) 99
TABLE 47 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 48 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 49 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 50 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 51 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS,
BY REGION, 2023–2030 (USD MILLION) 102
TABLE 52 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 102
TABLE 53 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 103
TABLE 54 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 103
TABLE 55 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 56 PREVALENCE OF DIABETES, 2024 104
TABLE 57 NUMBER OF ADULT PATIENTS WITH DIABETIC FOOT ULCERS, BY COUNTRY,
2023–2030 (THOUSANDS) 105
TABLE 58 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS,
BY REGION, 2023–2030 (USD MILLION) 105
TABLE 59 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 106
TABLE 60 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 106
TABLE 61 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 62 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 63 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS,
BY REGION, 2023–2030 (USD MILLION) 108
TABLE 64 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 65 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 66 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 67 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 110
TABLE 68 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS,
BY REGION, 2023–2030 (USD MILLION) 111
TABLE 69 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 70 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 112
TABLE 71 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 112
TABLE 72 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 73 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER,
2023–2030 (USD MILLION) 115
TABLE 74 HOSPITALS PER CAPITA, BY COUNTRY, 2025 116
TABLE 75 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 116
TABLE 76 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 77 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS,
BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 78 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 79 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 118
TABLE 80 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS,
BY REGION, 2023–2030 (USD MILLION) 119
TABLE 81 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 82 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 120
TABLE 83 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 120
TABLE 84 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 121
TABLE 85 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS,
BY REGION, 2023–2030 (USD MILLION) 121
TABLE 86 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 87 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 88 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 89 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 90 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY REGION,
2023–2030 (USD MILLION) 125
TABLE 91 NORTH AMERICA: KEY MACROECONOMIC INDICATORS 126
TABLE 92 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 127
TABLE 93 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 128
TABLE 94 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 128
TABLE 95 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 129
TABLE 96 US: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 130
TABLE 97 US: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 130
TABLE 98 US: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER,
2023–2030 (USD MILLION) 131
TABLE 99 CANADA: ESTIMATED PREVALENCE OF DIABETES, 2023–2024 131
TABLE 100 CANADA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 132
TABLE 101 CANADA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 132
TABLE 102 CANADA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER,
2023–2030 (USD MILLION) 133
TABLE 103 EUROPE: KEY MACROECONOMIC INDICATORS 134
TABLE 104 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 135
TABLE 105 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 135
TABLE 106 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 136
TABLE 107 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER,
2023–2030 (USD MILLION) 136
TABLE 108 UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 137
TABLE 109 UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 137
TABLE 110 UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER,
2023–2030 (USD MILLION) 138
TABLE 111 GERMANY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 139
TABLE 112 GERMANY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 139
TABLE 113 GERMANY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 139
TABLE 114 FRANCE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 140
TABLE 115 FRANCE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 141
TABLE 116 FRANCE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER,
2023–2030 (USD MILLION) 141
TABLE 117 ITALY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 142
TABLE 118 ITALY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 142
TABLE 119 ITALY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER,
2023–2030 (USD MILLION) 143
TABLE 120 SPAIN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 144
TABLE 121 SPAIN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 144
TABLE 122 SPAIN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER,
2023–2030 (USD MILLION) 144
TABLE 123 RUSSIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 145
TABLE 124 RUSSIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 146
TABLE 125 RUSSIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER,
2023–2030 (USD MILLION) 146
TABLE 126 REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 147
TABLE 127 REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 148
TABLE 128 REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET,
BY END USER, 2023–2030 (USD MILLION) 148
TABLE 129 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 149
TABLE 130 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 151
TABLE 131 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 151
TABLE 132 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 152
TABLE 133 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 152
TABLE 134 CHINA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 153
TABLE 135 CHINA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 154
TABLE 136 CHINA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER,
2023–2030 (USD MILLION) 154
TABLE 137 JAPAN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 155
TABLE 138 JAPAN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 155
TABLE 139 JAPAN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER,
2023–2030 (USD MILLION) 156
TABLE 140 INDIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 157
TABLE 141 INDIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE,
2023–2030 (USD MILLION) 157
TABLE 142 INDIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER,
2023–2030 (USD MILLION) 157
TABLE 143 AUSTRALIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 158
TABLE 144 AUSTRALIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 159
TABLE 145 AUSTRALIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 159
TABLE 146 SOUTH KOREA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 160
TABLE 147 SOUTH KOREA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 160
TABLE 148 SOUTH KOREA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 160
TABLE 149 SINGAPORE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 161
TABLE 150 SINGAPORE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 161
TABLE 151 SINGAPORE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 162
TABLE 152 REST OF ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 163
TABLE 153 REST OF ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET,
BY WOUND TYPE, 2023–2030 (USD MILLION) 163
TABLE 154 REST OF ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET,
BY END USER, 2023–2030 (USD MILLION) 163
TABLE 155 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 164
TABLE 156 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 157 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 165
TABLE 158 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 165
TABLE 159 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 166
TABLE 160 BRAZIL: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 167
TABLE 161 BRAZIL: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 167
TABLE 162 BRAZIL: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER,
2023–2030 (USD MILLION) 167
TABLE 163 MEXICO: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 168
TABLE 164 MEXICO: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 169
TABLE 165 MEXICO: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER,
2023–2030 (USD MILLION) 169
TABLE 166 REST OF LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 170
TABLE 167 REST OF LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET,
BY WOUND TYPE, 2023–2030 (USD MILLION) 170
TABLE 168 REST OF LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET,
BY END USER, 2023–2030 (USD MILLION) 170
TABLE 169 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS 171
TABLE 170 MIDDLE EAST & AFRICA: NEGATIVE PRESSURE WOUND THERAPY MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 172
TABLE 171 MIDDLE EAST & AFRICA: NEGATIVE PRESSURE WOUND THERAPY MARKET,
BY WOUND TYPE, 2023–2030 (USD MILLION) 172
TABLE 172 MIDDLE EAST & AFRICA: NEGATIVE PRESSURE WOUND THERAPY MARKET,
BY END USER, 2023–2030 (USD MILLION) 172
TABLE 173 NEGATIVE PRESSURE WOUND THERAPY MARKET: OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES, JANUARY 2022–MARCH 2025 174
TABLE 174 NEGATIVE PRESSURE WOUND THERAPY MARKET: DEGREE OF COMPETITION 177
TABLE 175 NEGATIVE PRESSURE WOUND THERAPY MARKET: REGION FOOTPRINT 181
TABLE 176 NEGATIVE PRESSURE WOUND THERAPY MARKET: PRODUCT TYPE FOOTPRINT 182
TABLE 177 NEGATIVE PRESSURE WOUND THERAPY MARKET: WOUND TYPE FOOTPRINT 183
TABLE 178 NEGATIVE PRESSURE WOUND THERAPY MARKET: END-USER FOOTPRINT 184
TABLE 179 NEGATIVE PRESSURE WOUND THERAPY MARKET: DETAILED LIST OF KEY STARTUPS/SMES 186
TABLE 180 NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 187
TABLE 181 NEGATIVE PRESSURE WOUND THERAPY MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025 190
TABLE 182 NEGATIVE PRESSURE WOUND THERAPY MARKET: DEALS,
JANUARY 2022–MARCH 2025 190
TABLE 183 NEGATIVE PRESSURE WOUND THERAPY MARKET: EXPANSIONS,
JANUARY 2022–MARCH 2025 192
TABLE 184 NEGATIVE PRESSURE WOUND THERAPY MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 193
TABLE 185 SOLVENTUM: COMPANY OVERVIEW 194
TABLE 186 SOLVENTUM: PRODUCTS OFFERED 195
TABLE 187 SOLVENTUM: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–MARCH 2025 196
TABLE 188 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 196
TABLE 189 SMITH+NEPHEW: COMPANY OVERVIEW 198
TABLE 190 SMITH+NEPHEW: PRODUCTS OFFERED 199
TABLE 191 SMITH+NEPHEW: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–MARCH 2025 200
TABLE 192 SMITH+NEPHEW: DEALS, JANUARY 2022–MARCH 2025 200
TABLE 193 SMITH+NEPHEW: EXPANSIONS, JANUARY 2022–MARCH 2025 201
TABLE 194 CARDINAL HEALTH: COMPANY OVERVIEW 203
TABLE 195 CARDINAL HEALTH: PRODUCTS OFFERED 204
TABLE 196 CARDINAL HEALTH: DEALS, JANUARY 2022–MARCH 2025 205
TABLE 197 CARDINAL HEALTH: EXPANSIONS, JANUARY 2022–MARCH 2025 206
TABLE 198 MÖLNLYCKE AB: COMPANY OVERVIEW 208
TABLE 199 MÖLNLYCKE AB: PRODUCTS OFFERED 209
TABLE 200 MÖLNLYCKE AB: DEALS, JANUARY 2022–MARCH 2025 210
TABLE 201 CONVATEC GROUP PLC: COMPANY OVERVIEW 212
TABLE 202 CONVATEC GROUP PLC: PRODUCTS OFFERED 213
TABLE 203 CONVATEC GROUP PLC: DEALS, JANUARY 2022–MARCH 2025 214
TABLE 204 PAUL HARTMANN AG: COMPANY OVERVIEW 215
TABLE 205 PAUL HARTMANN AG: PRODUCTS OFFERED 216
TABLE 206 PAUL HARTMANN AG: DEALS, JANUARY 2022–MARCH 2025 217
TABLE 207 AVERY DENNISON CORPORATION: COMPANY OVERVIEW 218
TABLE 208 AVERY DENNISON CORPORATION: PRODUCTS OFFERED 219
TABLE 209 AVERY DENNISON CORPORATION: DEALS, JANUARY 2022–MARCH 2025 220
TABLE 210 AVERY DENNISON CORPORATION: EXPANSIONS, JANUARY 2022–MARCH 2025 220
TABLE 211 BENQ MATERIALS CORPORATION: COMPANY OVERVIEW 221
TABLE 212 BENQ MATERIALS CORPORATION: PRODUCTS OFFERED 222
TABLE 213 BENQ MATERIALS CORPORATION: DEALS, JANUARY 2022–MARCH 2025 223
TABLE 214 BENQ MATERIALS CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2022–MARCH 2025 223
TABLE 215 ADVANCED OXYGEN THERAPY INC.: COMPANY OVERVIEW 224
TABLE 216 ADVANCED OXYGEN THERAPY INC.: PRODUCTS OFFERED 225
TABLE 217 ADVANCED OXYGEN THERAPY INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025 225
TABLE 218 DOUBLE MEDICAL TECHNOLOGY INC.: COMPANY OVERVIEW 226
TABLE 219 CARILEX MEDICAL: COMPANY OVERVIEW 227
TABLE 220 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW 228
TABLE 221 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW 229
TABLE 222 MEDAXIS LLC: COMPANY OVERVIEW 230
TABLE 223 GENADYNE BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW 231
TABLE 224 DIRECT HEALTHCARE GROUP: COMPANY OVERVIEW 232
TABLE 225 ALLEVA MEDICAL: COMPANY OVERVIEW 233
TABLE 226 CORK MEDICAL, LLC: COMPANY OVERVIEW 234
TABLE 227 PENSAR MEDICAL: COMPANY OVERVIEW 235
TABLE 228 HAROMED: COMPANY OVERVIEW 236
TABLE 229 GUANGZHOU RAINHOME PHARM & TECH CO., LTD.: COMPANY OVERVIEW 237
TABLE 230 GUARD MEDICAL: COMPANY OVERVIEW 238
TABLE 231 DATT MEDIPRODUCTS PRIVATE LIMITED: COMPANY OVERVIEW 239
TABLE 232 KORAZON MEDICAL DEVICES PRIVATE LIMITED: COMPANY OVERVIEW 240
TABLE 233 TRIAGE MEDITECH PVT. LTD.: COMPANY OVERVIEW 241
LIST OF FIGURES
FIGURE 1 NEGATIVE PRESSURE WOUND THERAPY MARKET SEGMENTATION
AND REGIONAL SCOPE 27
FIGURE 2 NEGATIVE PRESSURE WOUND THERAPY MARKET: RESEARCH DESIGN 31
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 35
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 36
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 37
FIGURE 6 NEGATIVE PRESSURE WOUND THERAPY MARKET: TOP-DOWN APPROACH 38
FIGURE 7 DATA TRIANGULATION METHODOLOGY 39
FIGURE 8 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE,
2025 VS. 2030 (USD MILLION) 42
FIGURE 9 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE,
2025 VS. 2030 (USD MILLION) 43
FIGURE 10 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 43
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF NEGATIVE PRESSURE WOUND THERAPY MARKET, 2025–2030 44
FIGURE 12 INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET 46
FIGURE 13 HOSPITALS SEGMENT AND CHINA LED ASIA PACIFIC MARKET IN 2024 47
FIGURE 14 CHINA TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030 48
FIGURE 15 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 48
FIGURE 16 NEGATIVE PRESSURE WOUND THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
FIGURE 17 NEGATIVE PRESSURE WOUND THERAPY MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 57
FIGURE 18 NEGATIVE PRESSURE WOUND THERAPY MARKET: VALUE CHAIN ANALYSIS 60
FIGURE 19 NEGATIVE PRESSURE WOUND THERAPY MARKET: SUPPLY CHAIN ANALYSIS 61
FIGURE 20 NEGATIVE PRESSURE WOUND THERAPY MARKET: ECOSYSTEM ANALYSIS 62
FIGURE 21 NEGATIVE PRESSURE WOUND THERAPY MARKET: INVESTMENT AND FUNDING SCENARIO, 2019–2025 63
FIGURE 22 NEGATIVE PRESSURE WOUND THERAPY MARKET: PATENT ANALYSIS,
JANUARY 2015–DECEMBER 2024 65
FIGURE 23 NEGATIVE PRESSURE WOUND THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS 77
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS 79
FIGURE 25 KEY BUYING CRITERIA FOR NEGATIVE PRESSURE WOUND THERAPY PRODUCTS 80
FIGURE 26 AI USE CASES 81
FIGURE 27 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET SNAPSHOT 127
FIGURE 28 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET SNAPSHOT 150
FIGURE 29 NEGATIVE PRESSURE WOUND THERAPY MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 175
FIGURE 30 NEGATIVE PRESSURE WOUND THERAPY MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 176
FIGURE 31 RANKING OF KEY PLAYERS IN NEGATIVE PRESSURE WOUND
THERAPY MARKET, 2024 178
FIGURE 32 NEGATIVE PRESSURE WOUND THERAPY MARKET:
COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 179
FIGURE 33 NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPANY FOOTPRINT 180
FIGURE 34 NEGATIVE PRESSURE WOUND THERAPY MARKET:
COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 185
FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 188
FIGURE 36 EV/EBITDA OF KEY VENDORS 188
FIGURE 37 NEGATIVE PRESSURE WOUND THERAPY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 189
FIGURE 38 SOLVENTUM: COMPANY SNAPSHOT (2024) 195
FIGURE 39 SMITH+NEPHEW: COMPANY SNAPSHOT (2024) 199
FIGURE 40 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 204
FIGURE 41 MÖLNLYCKE AB: COMPANY SNAPSHOT (2024) 209
FIGURE 42 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024) 213
FIGURE 43 PAUL HARTMANN AG: COMPANY SNAPSHOT (2024) 216
FIGURE 44 AVERY DENNISON CORPORATION: COMPANY SNAPSHOT (2024) 219
FIGURE 45 BENQ MATERIALS CORPORATION: COMPANY SNAPSHOT (2023) 222
FIGURE 46 ADVANCED OXYGEN THERAPY INC.: COMPANY SNAPSHOT (2024) 224
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11